<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03639506</url>
  </required_header>
  <id_info>
    <org_study_id>newivf20180817</org_study_id>
    <nct_id>NCT03639506</nct_id>
  </id_info>
  <brief_title>Clinical Application of Autologous Mitochondria Transplantation for Improving Oocyte Quality.</brief_title>
  <official_title>A Pilot Study of the Effect of Autologous Mitochondria Transplantation in Assisted Reproductive Technology Clinical Outcome.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sun Yat-sen University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sun Yat-sen University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Embryo quality was ranked as one of the most important predictors in determining the success&#xD;
      of implantation, while clinically some patients may experience repeated IVF failure due to&#xD;
      persistent poor embryo quality.Mitochondria, as the energy factory, is confirmed being a&#xD;
      hallmark of quality and developmental potential of human oocytes, and decreased mitochondria&#xD;
      copy number was reported to be associated with oocyte aging and dysfunctional mitochondria&#xD;
      would be expected to influence the late stages of oocyte maturation and early&#xD;
      embryogenesis.The objective of this study is to evaluate the effect of mitochondria transfer&#xD;
      from bone marrow mesenchymal stem cell on the quality of oocyte.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is a pilot study to investigate the effect of autologous mitochondria&#xD;
      transplantation for improving oocyte quality.&#xD;
&#xD;
      Design: randomized controlled trial. Setting: Assisted reproductive technologies unit.&#xD;
      Patients: patients who is in accordance with the inclusion criteria, and not meet the&#xD;
      exclusion criteria, who had repeated IVF treatment from Sep 2018 to Sep 2021.&#xD;
&#xD;
      Intervention: The comparison was made between mitochondria transfer（MIT) group and the&#xD;
      control group, both groups are conducted with the GnRH-a super-long protocol for IVF&#xD;
      treatment. MIT group injects autologous mitochondria from bone mesenchymal stem cells into&#xD;
      oocyte.&#xD;
&#xD;
      Main outcome measures: The primary outcome of the study is live birth rate. The secondary&#xD;
      outcomes were clinical pregnancy rate, number of oocytes retrieved, fertility rate, normal&#xD;
      fertilization rate, rate of transferable embryo and good quality embryo rate.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date type="Anticipated">September 2018</start_date>
  <completion_date type="Anticipated">September 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>live birth rate</measure>
    <time_frame>2-3years</time_frame>
    <description>number of live birth/ transferred cycle.Compare the live birth rate between the two groups with SPSS 20.0.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical pregnancy rate</measure>
    <time_frame>2-3years</time_frame>
    <description>Clinical pregnancy means pregnancy sac is seen intrauterine under ultrasound 7 weeks after embryo transferred.&#xD;
Clinical pregnancy rate(%): number of clinical pregnancy/transferred cycle.Compare the clinical pregnancy rate between the two group with SPSS 20.0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of oocytes retrieved</measure>
    <time_frame>2-3years</time_frame>
    <description>Compare the number of oocytes retrieved between the two group with SPSS 20.0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fertility rate</measure>
    <time_frame>2-3years</time_frame>
    <description>Fertility rate(%): number of oocyte fertilized/ number of oocytes retrieved.Compare the fertility rate between the two group with SPSS 20.0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>normal fertility rate</measure>
    <time_frame>2-3years</time_frame>
    <description>Normal fertility rate(%): number of oocyte normally fertilized/ number of oocytes retrieved. Compare the normal fertility rate between the two group with SPSS 20.0.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>good quality embryo rate</measure>
    <time_frame>2-3years</time_frame>
    <description>Cleavage embryo grades 1 or 2 with 6-10 blastomeres were considered good quality embryos. Good quality embryo rate(%): number of good quality embryo/number of fertilized oocytes.Compare the good quality embryo rate between the two group with SPSS 20.0.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Repetition Failure</condition>
  <arm_group>
    <arm_group_label>autologous mitochondria transplantation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>inject autologous mitochondria from bone marrow mesenchymal stem cells into oocyte as well as intracytoplasmic sperm injection (ICSI)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ICSI</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>only has intracytoplasmic sperm injection (ICSI)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>autologous mitochondria transplantation</intervention_name>
    <description>inject autologous mitochondria from bone marrow mesenchymal stem cells into oocyte</description>
    <arm_group_label>autologous mitochondria transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>autologous mitochondria from bone marrow mesenchymal stem cells into oocyte as well as intracytoplasmic sperm injection (ICSI)</intervention_name>
    <description>autologous mitochondria transplantation</description>
    <arm_group_label>autologous mitochondria transplantation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>intracytoplasmic sperm injection (ICSI)</intervention_name>
    <description>intracytoplasmic sperm injection (ICSI)</description>
    <arm_group_label>ICSI</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Women age &gt;20 years and &lt;43 years.&#xD;
&#xD;
          2. Anti-müllerian hormone（AMH） level ≥1.1 ng/ml.&#xD;
&#xD;
          3. Previous failed transfer cycle ≥2.&#xD;
&#xD;
          4. BMI&gt;18kg/m2 and &lt;25kg/m2.&#xD;
&#xD;
          5. Written informed consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Abnormal uterine development, endometrial adhesion or previous endometrial dysplasia&#xD;
             (&lt;7mm)&#xD;
&#xD;
          2. Other medical diseases that cannot be pregnant.&#xD;
&#xD;
          3. Complicated with adenomyosis, endometriosis confirmed by surgery, ovarian&#xD;
             endometriosis cyst ≥2 cm by ultrasound, all kind of malignant tumors or precancerous&#xD;
             disease.&#xD;
&#xD;
          4. Untreated hydrosalpinx.&#xD;
&#xD;
          5. The man has definite factors that affect the quality of the embryo, such as persistent&#xD;
             abnormal DNA fragment rate (&gt;30%) and non-obstructive spermatozoa.&#xD;
&#xD;
          6. Intracytoplasmic sperm injection with donor.&#xD;
&#xD;
        Eliminate or falls off Criteria:&#xD;
&#xD;
        1.The number of retrieved oocytes &lt;6.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>43 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Xiaoyan Liang, MD. Prof.</last_name>
    <phone>020-38048013</phone>
    <email>lxyzy@263.net</email>
  </overall_contact>
  <verification_date>August 2018</verification_date>
  <study_first_submitted>August 17, 2018</study_first_submitted>
  <study_first_submitted_qc>August 20, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 21, 2018</study_first_posted>
  <last_update_submitted>August 20, 2018</last_update_submitted>
  <last_update_submitted_qc>August 20, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">August 21, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Sun Yat-sen University</investigator_affiliation>
    <investigator_full_name>Yanhong Deng</investigator_full_name>
    <investigator_title>doctor</investigator_title>
  </responsible_party>
  <keyword>repetition failure</keyword>
  <keyword>autologous mitochondria transplantation</keyword>
  <keyword>embryo quality</keyword>
  <keyword>live birth rate</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

